Industry News

Vaccines Developed for Cancer and Infectious Diseases

Published in Cancer Weekly, February 15th, 2000

Immunomedics, Inc., Morris Plains, New Jersey, announced that it has received notification of a patent allowance by the U.S. Patent and Trademark Office for a new method of vaccination for cancers and infectious diseases.

"This patent is one of a number issued or pending in the field of vaccines," according to Dr. David M. Goldenberg, Immunomedics, Inc.

The subject of this new patent involves the "coating" of an alpha-galactose molecule on cancer cells or microorganisms by a fusion protein. Since patients have naturally-occurring antibodies to alpha-galactose, these antibodies can be turned on and can become therapeutic agents against cancers or...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-02-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry